Pre-order Enquiry
Request Free Sample
Global Solid Tumor Drug Market Insights and Forecast to 2028
SKU ID : QYR-20311603 | Publishing Date : 21-Feb-2022 | No. of pages : 107
Detailed TOC of Global Solid Tumor Drug Market Insights and Forecast to 2028
1 Study Coverage1.1 Solid Tumor Drug Product Introduction
1.2 Market by Type
1.2.1 Global Solid Tumor Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global Solid Tumor Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Radiology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Solid Tumor Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Solid Tumor Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Solid Tumor Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Solid Tumor Drug Sales by Region
2.4.1 Global Solid Tumor Drug Sales by Region (2017-2022)
2.4.2 Global Sales Solid Tumor Drug by Region (2023-2028)
2.5 Global Solid Tumor Drug Revenue by Region
2.5.1 Global Solid Tumor Drug Revenue by Region (2017-2022)
2.5.2 Global Solid Tumor Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Solid Tumor Drug Sales by Manufacturers
3.1.1 Global Top Solid Tumor Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Solid Tumor Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Solid Tumor Drug in 2021
3.2 Global Solid Tumor Drug Revenue by Manufacturers
3.2.1 Global Solid Tumor Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Solid Tumor Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Solid Tumor Drug Revenue in 2021
3.3 Global Solid Tumor Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Solid Tumor Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Solid Tumor Drug Sales by Type
4.1.1 Global Solid Tumor Drug Historical Sales by Type (2017-2022)
4.1.2 Global Solid Tumor Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Solid Tumor Drug Sales Market Share by Type (2017-2028)
4.2 Global Solid Tumor Drug Revenue by Type
4.2.1 Global Solid Tumor Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Solid Tumor Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Solid Tumor Drug Revenue Market Share by Type (2017-2028)
4.3 Global Solid Tumor Drug Price by Type
4.3.1 Global Solid Tumor Drug Price by Type (2017-2022)
4.3.2 Global Solid Tumor Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Solid Tumor Drug Sales by Application
5.1.1 Global Solid Tumor Drug Historical Sales by Application (2017-2022)
5.1.2 Global Solid Tumor Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Solid Tumor Drug Sales Market Share by Application (2017-2028)
5.2 Global Solid Tumor Drug Revenue by Application
5.2.1 Global Solid Tumor Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Solid Tumor Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Solid Tumor Drug Revenue Market Share by Application (2017-2028)
5.3 Global Solid Tumor Drug Price by Application
5.3.1 Global Solid Tumor Drug Price by Application (2017-2022)
5.3.2 Global Solid Tumor Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Solid Tumor Drug Market Size by Type
6.1.1 North America Solid Tumor Drug Sales by Type (2017-2028)
6.1.2 North America Solid Tumor Drug Revenue by Type (2017-2028)
6.2 North America Solid Tumor Drug Market Size by Application
6.2.1 North America Solid Tumor Drug Sales by Application (2017-2028)
6.2.2 North America Solid Tumor Drug Revenue by Application (2017-2028)
6.3 North America Solid Tumor Drug Market Size by Country
6.3.1 North America Solid Tumor Drug Sales by Country (2017-2028)
6.3.2 North America Solid Tumor Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Solid Tumor Drug Market Size by Type
7.1.1 Europe Solid Tumor Drug Sales by Type (2017-2028)
7.1.2 Europe Solid Tumor Drug Revenue by Type (2017-2028)
7.2 Europe Solid Tumor Drug Market Size by Application
7.2.1 Europe Solid Tumor Drug Sales by Application (2017-2028)
7.2.2 Europe Solid Tumor Drug Revenue by Application (2017-2028)
7.3 Europe Solid Tumor Drug Market Size by Country
7.3.1 Europe Solid Tumor Drug Sales by Country (2017-2028)
7.3.2 Europe Solid Tumor Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Solid Tumor Drug Market Size by Type
8.1.1 Asia Pacific Solid Tumor Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Solid Tumor Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Solid Tumor Drug Market Size by Application
8.2.1 Asia Pacific Solid Tumor Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Solid Tumor Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Solid Tumor Drug Market Size by Region
8.3.1 Asia Pacific Solid Tumor Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Solid Tumor Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Solid Tumor Drug Market Size by Type
9.1.1 Latin America Solid Tumor Drug Sales by Type (2017-2028)
9.1.2 Latin America Solid Tumor Drug Revenue by Type (2017-2028)
9.2 Latin America Solid Tumor Drug Market Size by Application
9.2.1 Latin America Solid Tumor Drug Sales by Application (2017-2028)
9.2.2 Latin America Solid Tumor Drug Revenue by Application (2017-2028)
9.3 Latin America Solid Tumor Drug Market Size by Country
9.3.1 Latin America Solid Tumor Drug Sales by Country (2017-2028)
9.3.2 Latin America Solid Tumor Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Solid Tumor Drug Market Size by Type
10.1.1 Middle East and Africa Solid Tumor Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Solid Tumor Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Solid Tumor Drug Market Size by Application
10.2.1 Middle East and Africa Solid Tumor Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Solid Tumor Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Solid Tumor Drug Market Size by Country
10.3.1 Middle East and Africa Solid Tumor Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Solid Tumor Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AstraZeneca Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Biogen
11.2.1 Biogen Corporation Information
11.2.2 Biogen Overview
11.2.3 Biogen Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Biogen Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biogen Recent Developments
11.3 Baxter
11.3.1 Baxter Corporation Information
11.3.2 Baxter Overview
11.3.3 Baxter Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Baxter Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Baxter Recent Developments
11.4 Celgene Corporation
11.4.1 Celgene Corporation Corporation Information
11.4.2 Celgene Corporation Overview
11.4.3 Celgene Corporation Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Celgene Corporation Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Celgene Corporation Recent Developments
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Corporation Information
11.5.2 Abbott Laboratories Overview
11.5.3 Abbott Laboratories Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Abbott Laboratories Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abbott Laboratories Recent Developments
11.6 Pfizer Inc
11.6.1 Pfizer Inc Corporation Information
11.6.2 Pfizer Inc Overview
11.6.3 Pfizer Inc Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Inc Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Inc Recent Developments
11.7 Amgen Limited & Amgen Ireland Limited
11.7.1 Amgen Limited & Amgen Ireland Limited Corporation Information
11.7.2 Amgen Limited & Amgen Ireland Limited Overview
11.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Amgen Limited & Amgen Ireland Limited Recent Developments
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Corporation Information
11.8.2 Bristol-Myers Squibb Company Overview
11.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bristol-Myers Squibb Company Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol-Myers Squibb Company Recent Developments
11.9 GlaxoSmithKline plc.
11.9.1 GlaxoSmithKline plc. Corporation Information
11.9.2 GlaxoSmithKline plc. Overview
11.9.3 GlaxoSmithKline plc. Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 GlaxoSmithKline plc. Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GlaxoSmithKline plc. Recent Developments
11.10 F. Hoffmann-La Roche Ltd.
11.10.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.10.2 F. Hoffmann-La Roche Ltd. Overview
11.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.11 Eli Lilly and Company
11.11.1 Eli Lilly and Company Corporation Information
11.11.2 Eli Lilly and Company Overview
11.11.3 Eli Lilly and Company Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Eli Lilly and Company Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Eli Lilly and Company Recent Developments
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Corporation Information
11.12.2 Johnson & Johnson Overview
11.12.3 Johnson & Johnson Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Johnson & Johnson Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Johnson & Johnson Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Solid Tumor Drug Industry Chain Analysis
12.2 Solid Tumor Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Solid Tumor Drug Production Mode & Process
12.4 Solid Tumor Drug Sales and Marketing
12.4.1 Solid Tumor Drug Sales Channels
12.4.2 Solid Tumor Drug Distributors
12.5 Solid Tumor Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Solid Tumor Drug Industry Trends
13.2 Solid Tumor Drug Market Drivers
13.3 Solid Tumor Drug Market Challenges
13.4 Solid Tumor Drug Market Restraints
14 Key Findings in The Global Solid Tumor Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figures, Tables and Charts Available in Global Solid Tumor Drug Market Insights and Forecast to 2028
List of TablesTable 1. Global Solid Tumor Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Small Molecules
Table 3. Major Manufacturers of Biologics
Table 4. Global Solid Tumor Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Solid Tumor Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Solid Tumor Drug Sales by Region (2017-2022) & (K MT)
Table 7. Global Solid Tumor Drug Sales Market Share by Region (2017-2022)
Table 8. Global Solid Tumor Drug Sales by Region (2023-2028) & (K MT)
Table 9. Global Solid Tumor Drug Sales Market Share by Region (2023-2028)
Table 10. Global Solid Tumor Drug Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Solid Tumor Drug Revenue Market Share by Region (2017-2022)
Table 12. Global Solid Tumor Drug Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Solid Tumor Drug Revenue Market Share by Region (2023-2028)
Table 14. Global Solid Tumor Drug Sales by Manufacturers (2017-2022) & (K MT)
Table 15. Global Solid Tumor Drug Sales Share by Manufacturers (2017-2022)
Table 16. Global Solid Tumor Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Solid Tumor Drug Revenue Share by Manufacturers (2017-2022)
Table 18. Solid Tumor Drug Price by Manufacturers (2017-2022) &(USD/MT)
Table 19. Global Solid Tumor Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Solid Tumor Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2021)
Table 21. Solid Tumor Drug Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Solid Tumor Drug Product Offered
Table 23. Date of Manufacturers Enter into Solid Tumor Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Solid Tumor Drug Sales by Type (2017-2022) & (K MT)
Table 26. Global Solid Tumor Drug Sales by Type (2023-2028) & (K MT)
Table 27. Global Solid Tumor Drug Sales Share by Type (2017-2022)
Table 28. Global Solid Tumor Drug Sales Share by Type (2023-2028)
Table 29. Global Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Solid Tumor Drug Revenue Share by Type (2017-2022)
Table 32. Global Solid Tumor Drug Revenue Share by Type (2023-2028)
Table 33. Solid Tumor Drug Price by Type (2017-2022) & (USD/MT)
Table 34. Global Solid Tumor Drug Price Forecast by Type (2023-2028) & (USD/MT)
Table 35. Global Solid Tumor Drug Sales by Application (2017-2022) & (K MT)
Table 36. Global Solid Tumor Drug Sales by Application (2023-2028) & (K MT)
Table 37. Global Solid Tumor Drug Sales Share by Application (2017-2022)
Table 38. Global Solid Tumor Drug Sales Share by Application (2023-2028)
Table 39. Global Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Solid Tumor Drug Revenue Share by Application (2017-2022)
Table 42. Global Solid Tumor Drug Revenue Share by Application (2023-2028)
Table 43. Solid Tumor Drug Price by Application (2017-2022) & (USD/MT)
Table 44. Global Solid Tumor Drug Price Forecast by Application (2023-2028) & (USD/MT)
Table 45. North America Solid Tumor Drug Sales by Type (2017-2022) & (K MT)
Table 46. North America Solid Tumor Drug Sales by Type (2023-2028) & (K MT)
Table 47. North America Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Solid Tumor Drug Sales by Application (2017-2022) & (K MT)
Table 50. North America Solid Tumor Drug Sales by Application (2023-2028) & (K MT)
Table 51. North America Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Solid Tumor Drug Sales by Country (2017-2022) & (K MT)
Table 54. North America Solid Tumor Drug Sales by Country (2023-2028) & (K MT)
Table 55. North America Solid Tumor Drug Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Solid Tumor Drug Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Solid Tumor Drug Sales by Type (2017-2022) & (K MT)
Table 58. Europe Solid Tumor Drug Sales by Type (2023-2028) & (K MT)
Table 59. Europe Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Solid Tumor Drug Sales by Application (2017-2022) & (K MT)
Table 62. Europe Solid Tumor Drug Sales by Application (2023-2028) & (K MT)
Table 63. Europe Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Solid Tumor Drug Sales by Country (2017-2022) & (K MT)
Table 66. Europe Solid Tumor Drug Sales by Country (2023-2028) & (K MT)
Table 67. Europe Solid Tumor Drug Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Solid Tumor Drug Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Solid Tumor Drug Sales by Type (2017-2022) & (K MT)
Table 70. Asia Pacific Solid Tumor Drug Sales by Type (2023-2028) & (K MT)
Table 71. Asia Pacific Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Solid Tumor Drug Sales by Application (2017-2022) & (K MT)
Table 74. Asia Pacific Solid Tumor Drug Sales by Application (2023-2028) & (K MT)
Table 75. Asia Pacific Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Solid Tumor Drug Sales by Region (2017-2022) & (K MT)
Table 78. Asia Pacific Solid Tumor Drug Sales by Region (2023-2028) & (K MT)
Table 79. Asia Pacific Solid Tumor Drug Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Solid Tumor Drug Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Solid Tumor Drug Sales by Type (2017-2022) & (K MT)
Table 82. Latin America Solid Tumor Drug Sales by Type (2023-2028) & (K MT)
Table 83. Latin America Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Solid Tumor Drug Sales by Application (2017-2022) & (K MT)
Table 86. Latin America Solid Tumor Drug Sales by Application (2023-2028) & (K MT)
Table 87. Latin America Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Solid Tumor Drug Sales by Country (2017-2022) & (K MT)
Table 90. Latin America Solid Tumor Drug Sales by Country (2023-2028) & (K MT)
Table 91. Latin America Solid Tumor Drug Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Solid Tumor Drug Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Solid Tumor Drug Sales by Type (2017-2022) & (K MT)
Table 94. Middle East and Africa Solid Tumor Drug Sales by Type (2023-2028) & (K MT)
Table 95. Middle East and Africa Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Solid Tumor Drug Sales by Application (2017-2022) & (K MT)
Table 98. Middle East and Africa Solid Tumor Drug Sales by Application (2023-2028) & (K MT)
Table 99. Middle East and Africa Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Solid Tumor Drug Sales by Country (2017-2022) & (K MT)
Table 102. Middle East and Africa Solid Tumor Drug Sales by Country (2023-2028) & (K MT)
Table 103. Middle East and Africa Solid Tumor Drug Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Solid Tumor Drug Revenue by Country (2023-2028) & (US$ Million)
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Major Businesses
Table 107. AstraZeneca Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 108. AstraZeneca Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. AstraZeneca Recent Developments
Table 110. Biogen Corporation Information
Table 111. Biogen Description and Major Businesses
Table 112. Biogen Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 113. Biogen Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Biogen Recent Developments
Table 115. Baxter Corporation Information
Table 116. Baxter Description and Major Businesses
Table 117. Baxter Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 118. Baxter Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Baxter Recent Developments
Table 120. Celgene Corporation Corporation Information
Table 121. Celgene Corporation Description and Major Businesses
Table 122. Celgene Corporation Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 123. Celgene Corporation Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Celgene Corporation Recent Developments
Table 125. Abbott Laboratories Corporation Information
Table 126. Abbott Laboratories Description and Major Businesses
Table 127. Abbott Laboratories Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 128. Abbott Laboratories Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Abbott Laboratories Recent Developments
Table 130. Pfizer Inc Corporation Information
Table 131. Pfizer Inc Description and Major Businesses
Table 132. Pfizer Inc Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 133. Pfizer Inc Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Pfizer Inc Recent Developments
Table 135. Amgen Limited & Amgen Ireland Limited Corporation Information
Table 136. Amgen Limited & Amgen Ireland Limited Description and Major Businesses
Table 137. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 138. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Amgen Limited & Amgen Ireland Limited Recent Developments
Table 140. Bristol-Myers Squibb Company Corporation Information
Table 141. Bristol-Myers Squibb Company Description and Major Businesses
Table 142. Bristol-Myers Squibb Company Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 143. Bristol-Myers Squibb Company Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Bristol-Myers Squibb Company Recent Developments
Table 145. GlaxoSmithKline plc. Corporation Information
Table 146. GlaxoSmithKline plc. Description and Major Businesses
Table 147. GlaxoSmithKline plc. Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 148. GlaxoSmithKline plc. Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. GlaxoSmithKline plc. Recent Developments
Table 150. F. Hoffmann-La Roche Ltd. Corporation Information
Table 151. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 152. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 153. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. F. Hoffmann-La Roche Ltd. Recent Developments
Table 155. Eli Lilly and Company Corporation Information
Table 156. Eli Lilly and Company Description and Major Businesses
Table 157. Eli Lilly and Company Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 158. Eli Lilly and Company Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Eli Lilly and Company Recent Developments
Table 160. Johnson & Johnson Corporation Information
Table 161. Johnson & Johnson Description and Major Businesses
Table 162. Johnson & Johnson Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 163. Johnson & Johnson Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Johnson & Johnson Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Solid Tumor Drug Distributors List
Table 168. Solid Tumor Drug Customers List
Table 169. Solid Tumor Drug Market Trends
Table 170. Solid Tumor Drug Market Drivers
Table 171. Solid Tumor Drug Market Challenges
Table 172. Solid Tumor Drug Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Solid Tumor Drug Product Picture
Figure 3. Global Solid Tumor Drug Market Share by Type in 2021 & 2028
Figure 3. Small Molecules Product Picture
Figure 4. Biologics Product Picture
Figure 5. Global Solid Tumor Drug Market Share by Application in 2021 & 2028
Figure 6. Oncology
Figure 7. Neurology
Figure 8. Radiology
Figure 9. Others
Figure 10. Solid Tumor Drug Report Years Considered
Figure 11. Global Solid Tumor Drug Sales 2017-2028 (K MT)
Figure 12. Global Solid Tumor Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Solid Tumor Drug Revenue 2017-2028 (US$ Million)
Figure 14. Global Solid Tumor Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Solid Tumor Drug Sales Market Share by Region (2017-2022)
Figure 16. Global Solid Tumor Drug Sales Market Share by Region (2023-2028)
Figure 17. North America Solid Tumor Drug Sales YoY (2017-2028) & (K MT)
Figure 18. North America Solid Tumor Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Solid Tumor Drug Sales YoY (2017-2028) & (K MT)
Figure 20. Europe Solid Tumor Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Solid Tumor Drug Sales YoY (2017-2028) & (K MT)
Figure 22. Asia-Pacific Solid Tumor Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Solid Tumor Drug Sales YoY (2017-2028) & (K MT)
Figure 24. Latin America Solid Tumor Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Solid Tumor Drug Sales YoY (2017-2028) & (K MT)
Figure 26. Middle East & Africa Solid Tumor Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Solid Tumor Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Solid Tumor Drug in the World: Market Share by Solid Tumor Drug Revenue in 2021
Figure 29. Global Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Solid Tumor Drug Sales Market Share by Type (2017-2028)
Figure 31. Global Solid Tumor Drug Revenue Market Share by Type (2017-2028)
Figure 32. Global Solid Tumor Drug Sales Market Share by Application (2017-2028)
Figure 33. Global Solid Tumor Drug Revenue Market Share by Application (2017-2028)
Figure 34. North America Solid Tumor Drug Sales Market Share by Type (2017-2028)
Figure 35. North America Solid Tumor Drug Revenue Market Share by Type (2017-2028)
Figure 36. North America Solid Tumor Drug Sales Market Share by Application (2017-2028)
Figure 37. North America Solid Tumor Drug Revenue Market Share by Application (2017-2028)
Figure 38. North America Solid Tumor Drug Sales Share by Country (2017-2028)
Figure 39. North America Solid Tumor Drug Revenue Share by Country (2017-2028)
Figure 40. U.S. Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Solid Tumor Drug Sales Market Share by Type (2017-2028)
Figure 43. Europe Solid Tumor Drug Revenue Market Share by Type (2017-2028)
Figure 44. Europe Solid Tumor Drug Sales Market Share by Application (2017-2028)
Figure 45. Europe Solid Tumor Drug Revenue Market Share by Application (2017-2028)
Figure 46. Europe Solid Tumor Drug Sales Share by Country (2017-2028)
Figure 47. Europe Solid Tumor Drug Revenue Share by Country (2017-2028)
Figure 48. Germany Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 49. France Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Solid Tumor Drug Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Solid Tumor Drug Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Solid Tumor Drug Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Solid Tumor Drug Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Solid Tumor Drug Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Solid Tumor Drug Revenue Share by Region (2017-2028)
Figure 59. China Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 62. India Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Solid Tumor Drug Sales Market Share by Type (2017-2028)
Figure 69. Latin America Solid Tumor Drug Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Solid Tumor Drug Sales Market Share by Application (2017-2028)
Figure 71. Latin America Solid Tumor Drug Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Solid Tumor Drug Sales Share by Country (2017-2028)
Figure 73. Latin America Solid Tumor Drug Revenue Share by Country (2017-2028)
Figure 74. Mexico Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Solid Tumor Drug Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Solid Tumor Drug Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Solid Tumor Drug Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Solid Tumor Drug Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Solid Tumor Drug Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Solid Tumor Drug Revenue Share by Country (2017-2028)
Figure 83. Turkey Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Solid Tumor Drug Revenue (2017-2028) & (US$ Million)
Figure 86. Solid Tumor Drug Value Chain
Figure 87. Solid Tumor Drug Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Keyplayers in Global Solid Tumor Drug Market Insights and Forecast to 2028
AstraZenecaBiogen
Baxter
Celgene Corporation
Abbott Laboratories
Pfizer Inc
Amgen Limited & Amgen Ireland Limited
Bristol-Myers Squibb Company
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Johnson & Johnson
Request Sample
Request Discount
